Frankly Speaking About Cancer with the Cancer Support Community

This episode takes a close look at the different aspects of treating and living with laryngeal cancer, or cancer of the larynx, which impacts the voice box. While it’s true that much will change, there is also a lot to be hopeful about. Our guests are Dr. Michael Moore, speech pathologist Kristen Beadle and cancer survivor Terry O’Brien.

This episode takes a close look at the different aspects of treating and living with laryngeal cancer, or cancer of the larynx, which impacts the voice box. While it’s true that much will change, there is also a lot to be hopeful about. Our guests are Dr. Michael Moore, speech pathologist Kristen Beadle and cancer survivor Terry O’Brien.

Chances are that you may never had heard of Utilization Management unless you’re in the industry, but you have probably heard of or experienced “prior authorization” and maybe even “Fail First.” Guest Elizabeth Franklin helps us understand what Utilization Management is, what are some of its common practices and techniques, and how it’s been impacted by the COVID-19 pandemic. We also look at the upcoming open enrollment period and the items that patients should look for when searching for a plan that is best for them.

Chances are that you may never had heard of Utilization Management unless you’re in the industry, but you have probably heard of or experienced “prior authorization” and maybe even “Fail First.” Guest Elizabeth Franklin helps us understand what Utilization Management is, what are some of its common practices and techniques, and how it’s been impacted by the COVID-19 pandemic. We also look at the upcoming open enrollment period and the items that patients should look for when searching for a plan that is best for them.

While the word mesothelioma may be familiar from various advertisements, most people will likely have never met someone diagnosed with this rare cancer. In this episode, we will discuss symptoms, diagnosis and treatments, including new approaches. Our guest to help us better understand this cancer is Dr. Rupesh Kotecha from Miami Cancer Institute.

While the word mesothelioma may be familiar from various advertisements, most people will likely have never met someone diagnosed with this rare cancer. In this episode, we will discuss symptoms, diagnosis and treatments, including new approaches. Our guest to help us better understand this cancer is Dr. Rupesh Kotecha from Miami Cancer Institute.

Remarkable progress has been made in the last few years improving treatment options and survival for women living with ovarian cancer. Joining us to get us up to speed on the most up to date information is Dr. Nita Lee.

Remarkable progress has been made in the last few years improving treatment options and survival for women living with ovarian cancer. Joining us to get us up to speed on the most up to date information is Dr. Nita Lee.

This episode is part of our special series, Looking at Leukemias, and we will be taking a close look at Chronic Myeloid Leukemia (CML). Improved treatment options for CML led to what is now one of the most controllable long-term cancers. While it requires daily medication and monitoring, with proper treatment, it can be managed. Join us as we take a close look at this leukemia and discuss how to live your best life with a chronic cancer. Our guests are Dr. Kendra Sweet from the Moffitt Cancer Center in Tampa, Florida and Diane Krupnick, who has been living with CML for over 5 years.

This episode is part of our special series, Looking at Leukemias, and we will be taking a close look at Chronic Myeloid Leukemia (CML). Improved treatment options for CML led to what is now one of the most controllable long-term cancers. While it requires daily medication and monitoring, with proper treatment, it can be managed. Join us as we take a close look at this leukemia and discuss how to live your best life with a chronic cancer. Our guests are Dr. Kendra Sweet from the Moffitt Cancer Center in Tampa, Florida and Diane Krupnick, who has been living with CML for over 5 years.